Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$20.24 - $29.16 $403,949 - $581,975
-19,958 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$4.45 - $6.2 $88,813 - $123,739
19,958
19,958 $112,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.77B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.